Risk assessment after myocardial infarction: have the rules changed with thrombolytic therapy?.
Verani
M S
MS
Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA.
D006328:Cardiac Catheterization; D003326:Coronary Circulation; D005080:Exercise Test; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D009203:Myocardial Infarction / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000503:physiopathology*; D018579:Patient Selection; D011379:Prognosis; D011877:Radionuclide Imaging; D018570:Risk Assessment; D013318:Stroke Volume; D015912:Thrombolytic Therapy; D014665:Vasodilator Agents; D016277:Ventricular Function, Left
D005343:Fibrinolytic Agents; D014665:Vasodilator Agents